Potential role of human papillomavirus proteins associated with the development of cancer

Papillomaviruses are viruses with double-stranded DNA that are epitheliotropic and non-enveloped that infect cutaneous epithelial and mucosal cells in a species-specific way in several higher vertebrate species and cause cellular growth. The most prevalent cause of death worldwide is cancer.

Published in Biomedical Research

Potential role of human papillomavirus proteins associated with the development of cancer
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

SpringerLink
SpringerLink SpringerLink

Potential role of human papillomavirus proteins associated with the development of cancer - VirusDisease

Papillomaviruses are viruses with double-stranded DNA that are epitheliotropic and non-enveloped that infects cutaneous epithelial and mucosal cells in a species-specific way in several higher vertebrate species and cause cellular growth.“There are around 100 different human papillomaviruses (HPVs)”, as “more than 150 HPV types have been isolated and fully sequenced”. We classify the probability of cancer development following viral infection with each HPV genotype into two types: “low-risk” and “high-risk.” As a result, HPV diagnosis is a critical component of HPV genotype identification and characterization. Based on its activities, we may classify the HPV genome into three regions: the long control region (LCR) or the non-coding upstream regulatory region (URR), the late (L) region, and the early (E) region. Functional proteins are mostly static things that are not inflexible; they have undergone both local and global movements at various times and time ranges. The structural differences between HPV16 and 18 discovered by molecular modeling of the E6 oncoprotein were associated with their carcinogenic characteristics. Similarly, the E6 protein has two sets of C-X-X-C motifs that play significant roles in transformation, transcriptional activation, interactions, and immortalization with other proteins of cells in the host environment. Here, we review the literature regarding the protein mechanisms associated with HPV and how they cause cancer. Unless otherwise noted, it described all protein activities in terms of HPV proteins. The term “papillomaviruses” refers to groups of papillomavirus proteins that have a characteristic in common. HPV proteins can study the genetic influences on pathogenicity and the therapeutic applications of genomics. The future study provides a potential advancement in HPV infections and malignant illnesses to improve preventive and treatment strategies. Patients have been able to conquer this condition using a range of therapies and vaccines that were projected to be effective and robust enough to put an end to the ailment completely. In cancer prevention strategies, HPV vaccination is one of the most effective. It is safe, efficient, and long-lasting.

HPVs are a significant cause of illness and death globally. Around 5% of all malignancies in the world and 600,000 cancer occurrences are linked with HPV. Identifying the many HPV strains that cause disease has resulted in improved diagnostic, screening, and preventative measures for the medical community. As the infected cell is forcibly driven to resume DNA replication, E6 performs several functions, interfering with several cellular pathways to establish a conducive environment for viral replication and neutralizing the cellular surveillance mechanisms that are turned on. Oncogenic HPV strains share an ancestral lineage, according to the most recent research. The precise genetic basis for HPV oncogenicity is complicated and will need new analytic techniques. As a model for non-recombinant genome evolution, pathogenicity, genetic factors, and genomic applications for therapeutic use, the HPV genome may be studied. Large-scale investigations will offer protein interactions of HPV high-risk genotypes, and advanced evaluations with progressing tumours (Stage III, IV) will be necessary to validate these present findings for future HPV research. this data will serve as a baseline for vaccination programs. We should screen women with a family history
of cancer for HPV at regular intervals and genetic testing for oncogenes. Improved knowledge of the infection’s genomic features and microenvironment may lead to novel therapeutic interventions, such as preventative vaccinations. In addition,
the genomic studies of this virus might help cure existing lesions and limit the risk of HPV-related malignancies.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in